美股夜盘交易时段，Aurinia Pharmaceuticals Inc（AUPH）股价大涨5.04%，引发市场关注。这一显著涨幅很可能与公司董事近期的大规模增持行为有关。
根据美国证券交易委员会（SEC）8月5日披露的文件，Aurinia Pharmaceuticals的董事TANG KEVIN于8月1日、4日和5日连续三天增持公司股票。TANG KEVIN以平均每股10.45美元的价格购入了130万股普通股，总价值约为1359万美元。这一大手笔增持行为向市场传递了公司内部对公司前景持积极态度的信号。
内部人士，尤其是公司董事的大规模增持通常被视为对公司未来发展前景看好的强烈信号。这种行为往往能够提振投资者信心，刺激股价上涨。TANG KEVIN的增持行为恰逢其时，可能是引发Aurinia Pharmaceuticals股价在夜盘交易中大幅上涨的主要原因。投资者应继续关注公司后续发展及可能的进一步内部交易情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.